GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by ...
GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase...
If approved, Novo Nordisk's Ozempic will become the first GLP-1 therapy option f...
J&J’s BLA was supported by data from the Phase III VIVACITY study, demonstrating...
Alnylam announced positive final results from the Helios-B trial for patients wi...
Experts discuss the relationship between obesity and heart failure while referen...
GlobalData tracks 15 drugs in development for Acute On Chronic Liver Failure (AC...
GlobalData tracks 19 drugs in development for Non-infectious Uveitis by 20 compa...
GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor b...
Rybrevant has been granted a Type II approval extension to treat NSCLC with EGFR...
Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox cla...
The deal included an undisclosed upfront payment and NextRNA can get up to $547m...
Arcus turned to Hercules Capital’s financing for support and to advance its HIF-...
The FDA also plans to hold an advisory committee for the DCCR therapy for Prader...
With new oesophageal cancer cases annually projected to increase by 80% before 2...
Navigator Medicines has secured $100m in a Series A financing round with the aim...
